Russell Tobin

Closed
yelp logo

(41)

Photos

420 Lexington Ave Rm 2220
New York, NY 10170

Russell Tobin is a prominent employment agency located in the heart of New York, NY. Specializing in connecting top talent with leading companies, they offer a range of staffing solutions across various industries. With a focus on personalized service, Russell Tobin is dedicated to helping job seekers find their ideal positions while supporting businesses in their hiring needs.

Generated from this place's information

Reviews

yelp logo
2.041 reviews
Photo of Jules C.
Jules C.
4/25/2018

Three cheers for Russell Tobin - these guys helped me secure a great gig. My recruiter was Olivia Karcz. Beautiful office space. My initial meeting with them was only about five-ten minutes...

Bethany L.
12/15/2024

I got an email from Efrata Feleke, and soon after got a text from her asking if I had time to talk about a position with 3M. I found her LinkedIn and decided that it was worth it to call her. She...

Ella K.
8/9/2024

Unprofessional approach to candidates. I would not recommend working with this stuffing agency.

Photo of Stacey R.
Stacey R.
2/23/2022

The representative of Russell Tobin found the perfect position for me at a reputable company. From the time of them notifying me about the job to my interview to my acceptance letter happened in...

Katherine K.
5/2/2022

Total Scam, steer clear, they will try to get your personal information like Social Security number and DOB. Do not trust them under any circumstances.

Own this business?
See a problem?

You might also like

Jack Kelly & Partners LLC
Real estate managers, Art gallery, Investment advisory service

Jack Kelly & Partners LLC

New Leaf Venture Partners' objectives with each investment are to back a strong, entrepreneurial management team, to provide appropriate financial resources, to help build a great company, and to create exceptional equity value. We are active investors and almost always serve as directors of our portfolio companies, who can draw upon perspectives and experiences of the entire NLV investment team and its network of successful scientists, clinicians, operating executives and entrepreneurs. We assist in building management teams, guiding corporate strategy, providing input to operating plans, and in making decisions about optimal paths for future financings and exits. As conditions evolve, NLV Partners team continually refines its differentiated strategy in healthcare investing. Both of NLV's latest funds, New Leaf Ventures I and New Leaf Ventures II, focus on taking leadership positions in: Biopharmaceuticals - NLV has an in-depth understanding of therapeutic targets and modalities, the drug R&D process, clinical trial design, regulatory requirements, and pharmaceutical commercial activities. NLV's extensive medical, clinical development, commercial and financial experience helps companies navigate the challenging path to regulatory approval and commercialization as stand-alone companies or through value-added strategic partnerships. NLV invests in companies at all stages in this sector, but looks at the level of risk, costs, and timelines to build real value in the underlying program (s) in determining if an investment fits our strategy. NLV has been particularly active in starting and investing in companies that been formed around the spin out of programs from larger pharmaceutical and biotech companies. Medical devices - NLV works closely with its network of entrepreneurs and scientific and medical founders to identify investment opportunities around promising technologies targeting areas of high unmet medical need and large commercial potential. The current strategy is to focus on later stage opportunities to provide growth capital or the last round to profitability in which regulatory and reimbursement risks are minimal. NLV will invest in early stage companies when there are large established global markets and an opportunity to prove safety and effectiveness in a focused, cost effective program. NLV's investment team brings critical operating experience and the ability to evaluate the biological, engineering, regulatory, reimbursement and market risks most relevant to starting, growing, developing and exiting young or more mature companies in the medical devices sector.
United StatesNew YorkNew YorkRussell Tobin

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.